Animal Gut & Microbiome Health, 2018: Global Commercial Strategies & Future Challenges -

DUBLIN--()--The "Gut and Microbiome Health: Commercial Strategies and Future Challenges" report has been added to's offering.

This report provides an in-depth scientific perspective on animal gut and microbiome health, which is a relatively new but fast-evolving segment.

The report focuses on the gastrointestinal microbiome and its impact in animal health. A well-functioning and stable microbiome is important in maintaining good gastrointestinal health.

This is especially vital in the poultry and pig industries where gastrointestinal diseases pose a major challenge. This report explores current and future market opportunities including analysis of the barriers to entry and further development.

Key Insights

  • Commercial strategies and market sizing
  • Global company insights - examples of products and programmes
  • Some of the key players covered in the report are
  • R&D and future challenges to growth strategy of leading firms
  • Role of antibiotics and feed components across animal species

Companies Mentioned

  • Addisseo
  • ADM
  • Associated British Nutrition
  • Alltech
  • Biomin
  • Chr. Hansen
  • Delacon
  • Du-Pont
  • Evonik
  • Kemin Industries
  • Lallemand
  • Novozymes
  • Novus International
  • Perstorp
  • Pfizer/Zoetis
  • Royal DSM

Topics Covered

Executive Summary

Chapter 1: Gastrointestinal Tract Structure

1.1 Structure

1.1.1. Mucus Layer

1.1.2. Epithelial Layer

1.1.3. Gut-Associated Lymphoid Tissue (GALT)

Chapter 2: Nature of Microbiome

2.1 Function of the Microbiome

2.2 Techniques for Analysis of the Microbiome

2.3 Number of Micro-Organisms

2.4 Types of Micro-Organisms

2.4.1. Avian Species

2.4.2. Pigs

2.4.3. Ruminants

2.5 Biochemical Activities of the Microbiome

2.6 Development of the Microbiome with Age

2.6.1. Avian Species

2.6.2. Pigs

2.6.3. Ruminants

Chapter 3: Interaction of the Microbiome and Animal Health and Growth

3.1 Gastrointestinal Health

3.2 Significance of the Microbiome

3.3 Microbiome and Diseases

3.3.1. Avian Species

3.3.2. Pigs

3.3.3. Ruminants

3.4 Influence on the Immune System

3.5 Long-Distance effects of the Microbiome through the Gut-Brain Axis

3.6 Antibiotic Resistance

Chapter 4: Modulation of the Gastrointestinal Microbiome

4.1 Modulation of the Microbiome

4.2 Antibiotics

4.3 Feed Components

4.3.1. Organic Acids

4.3.2. Feed Enzymes

4.3.3. Prebiotics

4.3.4. Probiotics

4.3.5. Phytochemicals (Phytobiotics)

4.3.6. Zinc Oxide

Chapter 5: Commercial Strategies and Market Size

5.1 Programmes of Various Companies

5.2 Products and Market Size

Chapter 6: Future Challenges to Manage the Gastrointestinal Microbiome to Support Animal Health

6.1 Manage the Microbiome

6.2 Develop the Microbiome

6.3 Feed the Microbiome as well as the Animal

6.3.1. Feed Enzymes

6.3.2. Human Milk Oligosaccharides

6.4. Maintain Microbial Stability

6.5 Manage Stress

6.6 Product Innovation

6.6.1. 2-Aminoimidazole

6.6.2. Predatory Bacteria

6.6.3. Dead Probiotics

6.6.4. Valeric Acid

Chapter 7: Conclusions

Chapter 8: References

List of Figures

Figure 1: The interactions between nutrition, the gastrointestinal tract and the microbiome

Figure 2: Gastrointestinal microbiome and brain-gut-axis (Adams and Gutierrez, 2018)

List of Tables

Table 1: Average microbiome composition in caecum of broilers

Table 2: Effects of oligofructose overload on average relative abundance of phylum level in rumen content

Table 3: Effect of fructooligosaccharide on bacteria (cfu/g dry matter) in the caecal contents of broilers at 49 days of age

Table 4: Vancomycin-resistant enterococci (VRE) detection (%) in cloacal swabs of broiler chicks treated with live or dead probiotic cells

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biopharmaceuticals

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biopharmaceuticals